Tianchen Biopharma

天辰生物

Tianchen Biopharma

Biotech/Healthcare

Tianchen Biotech is dedicated to developing differentiated next-generation large-molecule antibodies for autoimmune diseases. Its R&D pipeline focuses on unmet clinical needs in the autoimmune disease field, with multiple candidates progressing steadily.

Latest round: Series C (2025)

Source: ChinaBulls — chinabulls.com

Last updated 2025-06-01